Biopharma in 2019
Is the Biotech Bull Market Over?
FDA Lifts Clinical Hold; Green-Lights Vertex and CRISPR’s Sickle Cell Gene Therapy Trial
FDA clears Vertex, CRISPR to test gene-editing therapy in sickle cell patients
Amicus muscles in on Pompe gene therapy chase
Gene therapy deal-making shows no signs of stopping
CRISPR Therapeutics and ViaCyte Collaborate to Tackle Type 1 Diabetes
US Companies Launch CRISPR Clinical Trial
CRISPR, Vertex launch first company-backed gene editing trial in humans
We’ve been hearing about CRISPR since 2012, and excitement has been mounting about this molecular tool that can add, remove, or exchange a DNA sequence within the genome of … Continue Reading 5 Things to Know About CRISPR
CRISPR technology offers the promise to cure any human genetic disease. Which are the candidates to be the first one? CRISPR-Cas9 was first described as a gene editing tool in … Continue Reading 7 Diseases CRISPR Technology Could Cure
In 2016, German pharma giant Bayer took a bold step and decided to partner with CRISPR Therapeutics to form a company that could join the race to be first into … Continue Reading The Race to Get CRISPR to the Clinic: Hope Versus Hype
Genomic medicine is the future of healthcare. Spawned by the Human Genome Project (“HGP”), this precise and personal approach to medicine is an emerging discipline with enormous disruptive … Continue Reading Genomic Medicine: Catch The Gene Therapy Wave
One of the most promising and exciting healthcare innovations in decades is genomic editing technology using CRISPR technology to repair defective genetic material that causes disease. CRISPR is an … Continue Reading Is Genome Editing the Next Biotech Breakthrough?
Shares of CRISPR Therapeutics plunged dramatically Wednesday after the U.S. Food and Drug Administration (FDA) placed a clinical hold on a planned sickle cell disease treatment the company was in … Continue Reading FDA Chains Clinical Hold on CRISPR/ Vertex Sickle Cell Disease IND
Two papers published today in Nature Medicine are raising a new potential red flag with CRISPR-Cas9 gene editing: Human cells that are successfully edited in the lab may have a … Continue Reading CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells